Sign In
Buy HQL
$18.63
+0.290 (+1.58%)
At Close: Jun 23, 2026
The global nutrigenomics market size will grow by USD 425.61 million during 2020-2024
Forget Gilead, These 2 Pharma Dividends Pay Up To 10%
12:00am, Monday, 04'th May 2020
Stocks Analysis by Contrarian Outlook (Michael Foster) covering: S&P 500, Microsoft Corporation, Gilead Sciences Inc, Alphabet Inc Class A. Read Contrarian Outlook (Michael Foster)'s latest article on
Tekla World Healthcare Fund Paid Distribution
02:28pm, Thursday, 30'th Apr 2020
On April 30, 2020, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is d
Tekla Healthcare Opportunities Fund Paid Distribution
02:20pm, Thursday, 30'th Apr 2020
On April 30, 2020, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other cap
2 Healthcare CEFs To Outperform: HQH And THW, Yields Up To 10%
12:20pm, Thursday, 30'th Apr 2020
Following the current crisis, healthcare stocks have been getting more attention. The reason is simple: More spending will go to healthcare, particularly biotec
The Best And Worst-Performing CEFs YTD, And 5 To Buy Now: April 2020
09:35am, Wednesday, 22'nd Apr 2020
We analyze trends in closed-end-fund returns data by asset class and sectors. Our views on themes to watch in the year ahead. 5 CEFs we recommend to buy now.
Tekla Life Sciences Investors (NYSE:HQL) Shares Sold by Bank of America Corp DE
08:58am, Monday, 20'th Apr 2020
Bank of America Corp DE cut its holdings in shares of Tekla Life Sciences Investors (NYSE:HQL) by 12.0% during the fourth quarter, according to the company in its most recent disclosure with the Secur
Wither Thou Goest
02:22pm, Thursday, 09'th Apr 2020
I haven't seen a need for an update to the Protected Principal Retirement Portfolio (PPRP) since the virus/oil price war etc. crises have hit. Have made some mi
Tekla Life Sciences Investors (NYSE:HQL) Shares Sold by Ladenburg Thalmann Financial Services Inc.
10:58am, Tuesday, 07'th Apr 2020
Ladenburg Thalmann Financial Services Inc. trimmed its holdings in shares of Tekla Life Sciences Investors (NYSE:HQL) by 20.1% during the fourth quarter, Holdings Channel reports. The firm owned 49,43
Guggenheim Capital LLC Acquires 7,370 Shares of Tekla Life Sciences Investors (NYSE:HQL)
10:02am, Tuesday, 07'th Apr 2020
Guggenheim Capital LLC raised its position in Tekla Life Sciences Investors (NYSE:HQL) by 44.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities
1832 Asset Management L.P. Purchases 45,934 Shares of Tekla Life Sciences Investors (NYSE:HQL)
08:12am, Wednesday, 01'st Apr 2020
1832 Asset Management L.P. boosted its position in Tekla Life Sciences Investors (NYSE:HQL) by 57.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 125
Tekla World Healthcare Fund Paid Distribution
02:39pm, Tuesday, 31'st Mar 2020
On March 31, 2020, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital sou
Advisors Asset Management Inc. Buys 62,317 Shares of Tekla Life Sciences Investors (NYSE:HQL)
08:26am, Sunday, 29'th Mar 2020
Advisors Asset Management Inc. grew its stake in Tekla Life Sciences Investors (NYSE:HQL) by 88.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchang
Citigroup Inc. Buys 5,977 Shares of Tekla Life Sciences Investors (NYSE:HQL)
10:56am, Thursday, 26'th Mar 2020
Citigroup Inc. lifted its stake in shares of Tekla Life Sciences Investors (NYSE:HQL) by 75.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm
Tekla Life Sciences Investors (NYSE:HQL) Shares Bought by Raymond James Financial Services Advisors Inc.
09:12am, Tuesday, 24'th Mar 2020
Raymond James Financial Services Advisors Inc. raised its holdings in Tekla Life Sciences Investors (NYSE:HQL) by 17.0% in the fourth quarter, according to its most recent 13F filing with the Securiti
